Zur Kurzanzeige

dc.contributor.authorGomes-Ferreira, Monica Morais
dc.contributor.authorLapresa Alcalde, Victoria
dc.contributor.authorGarcía Sánchez, María Elena 
dc.contributor.authorHernández Hernández, María Lourdes 
dc.contributor.authorDoyagüe Sánchez, María José 
dc.date.accessioned2021-06-02T09:52:46Z
dc.date.available2021-06-02T09:52:46Z
dc.date.issued2018
dc.identifier.citationFerreira, M. G., Alcalde, V. L., Sánchez, M. H. G., Hernández, L. H., & Doyague Sánchez, M. J. (2018). Successful treatment of anti-NMDA receptor encephalitis with early teratoma removal and plasmapheresis: A case report. Medicine, 97(31), 11325. https://doi.org/10.1097/MD.0000000000011325es_ES
dc.identifier.issn0025-7974
dc.identifier.urihttp://hdl.handle.net/10366/146665
dc.description.abstract[EN]Rationale: This report describes a Successful treatment of anti-NMDA receptor encephalitis with early teratoma removal and plasmapheresis. Patient Concerns: We present a 31-year-old Caucasian nulliparous patient who was admitted as an emergency with general illness status accompanied by holocranial cephalalgia and fever. Diagnoses: The previous symptoms were followed by disorientation, persecutory delusion, incoherent language, and tonic-clonic seizure. Interventions: The patient was admitted in the intensive care unit (ICU) with Glasgow score 7. Outcomes: Most of complementary exams (brain CT, brain MRI, blood analysis, PCR for virus on CSF) were normal except CSF leucocytosis and hyperproteinorrhachia. An abdominopelvic ultrasound revealed a 5-cm solid-cystic tumor in the left adnexal region, suggestive of teratoma. At that stage, the possibility of autoimmune encephalitis was considered, and confirmed later. Lessons: This disease can only be successfully treated with fast surgical intervention and an early implementation of immunosuppressive therapies. The optimal timing of initiation and duration of therapeutic plasma exchange necessary to achieve good outcomes in patients with NMDAR remains unknown. This case report intends to increase awareness about the importance of early surgical treatment and early implementation of this potentially life-saving therapy and of continuing the treatment until complete remission of symptoms.es_ES
dc.language.isoenges_ES
dc.publisherLippincott Williams and Wilkinses_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAnti-NMDA receptor encephalitises_ES
dc.subjectOvarian teratoma removales_ES
dc.subjectPlasmapheresises_ES
dc.subjectSurvivales_ES
dc.subjectYoung womanes_ES
dc.subject.meshPlasmapheresis*
dc.subject.meshEncephalitis*
dc.subject.meshTeratoma*
dc.titleSuccessful treatment of anti-NMDA receptor encephalitis with early teratoma removal and plasmapheresises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversion10.1097/MD.0000000000011325es_ES
dc.subject.unesco3201.08 Ginecologíaes_ES
dc.subject.unesco3201.01 Oncologíaes_ES
dc.identifier.doi10.1097/MD.0000000000011325
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.journal.titleMedicinees_ES
dc.volume.number97es_ES
dc.issue.number31es_ES
dc.page.initiale11325es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsencefalitis*
dc.subject.decsplasmaféresis*
dc.subject.decsteratoma*


Dateien zu dieser Ressource

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Solange nicht anders angezeigt, wird die Lizenz wie folgt beschrieben: Attribution-NonCommercial-NoDerivatives 4.0 Internacional